laboratory
>
research
>
assay of bacterial and viral genomes
laboratory
technology
publications
news
contacts
assay of bacterial and viral genomes
Head of the group: PhD (biology) D.A. Gryadunov
Identification of mutations resulting in drug resistance in M. tuberculosis
against rifampicin and isoniazid: the drugs which are most effective against
M. tuberculosis
infection. Test-system
TB-BIOCHIP
®
against other drugs (fluoroquinolones). Test-system
TB-BIOCHIP-2
®
genotyping of bacteria of M. tuberculosis complex
genetic differentiation of mycobacteria
Detection of the main viral transfusion-transmitted infections (HIV, hepatitis B and C) ("SI-Biochip")
Identification of genotype and subtype of hepatitis C virus
Differentiation of Orthopox- and Herpesviruses
Detection of causative agents (viruses) of neonatal infections
Identification of influenza A virus subtypes
Analysis of drug-resistance of HIV
Detection of causative agents of extremely dangerous infections
research
development of methods for nucleic acids analysis (hybridization, PCR, RCA, cartridge for DNA isolation)
assay of bacterial and viral genomes
human genome analysis
ligand- and protein-DNA binding
biochips for proteomic studies
fluorescent labeling of oligonucleotides
synthesis of oligonucleotides
development of Hard- and Software-based Complexes for the analysis of biological microchips (Fluorescent Biochip-analyzers)
simultaneous quantitative immunoassay of several antigens, biotoxins, etc.
mass spectrometry
development of biochip manufacturing technology
creation of pilot-scale production of biochips and biochip-based test-systems
Engelhardt Institute of Molecular Biology Russian Academy of Sciences
Vavilov str., 32 Moscow 119991, Russia
phone (+7499) 135-05-59
www.eimb.ru
, info@biochip.ru
© All rights reserved, 2010
